Goa, India

Jawed Hussain

This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Ratiopharm Gmbh. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jawed Hussain. Retrieved from https://idiyas.com/inventor/jawed-hussain

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Jawed Hussain in Pharmaceutical Composition

Introduction

Jawed Hussain is a notable inventor based in Goa, India. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on Escitalopram. His research focuses on improving the efficacy and delivery of this important medication.

Latest Patents

Jawed Hussain holds a patent for "Escitalopram and solid pharmaceutical composition comprising the same." This invention relates to Escitalopram that has a small median particle size, enhancing its effectiveness in solid pharmaceutical compositions. His work in this area demonstrates a commitment to advancing medical treatments.

Career Highlights

Hussain is associated with Ratiopharm GmbH, where he applies his expertise in pharmaceutical development. His role at the company allows him to contribute to the creation of innovative drug formulations that can improve patient outcomes.

Collaborations

Some of his notable coworkers include Parshwakumar V Kalyankar and Ganesh Vinayak Gat. Their collaboration in research and development has likely played a role in the success of their projects.

Conclusion

Jawed Hussain's contributions to the pharmaceutical industry, particularly through his patent on Escitalopram, highlight his innovative spirit and dedication to improving healthcare solutions. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…